UK MHRA acts to support development of novel devices
This article was originally published in RAJ Devices
Executive Summary
The UK Medicines and Healthcare products Regulatory Agency has developed a new section on its website on emerging medical technologies1. The aim is to help companies understand the impact of the medical devices directives on their novel technology and to encourage device sponsors to engage in early dialogue with the agency.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EMA Hopes New Requirement Will Make Companies Stick To Their Filing Plans
An additional form that marketing authorization applicants must now complete during the pre-submission stage emphasizes the importance of companies providing accurate information on their intended submission date.
EMA To Get The Ball Rolling On Making CTIS Global
The European Medicines Agency wants to further improve the visibility of data in the Clinical Trials Information System by establishing it as a World Health Organization primary registry.